Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$414K Buy
+7,017
New +$442K ﹤0.01% 2664
2025
Q3
Sell
-21,623
Closed -$785K 2805
2025
Q2
$785K Buy
21,623
+9,933
+85% +$276K ﹤0.01% 1381
2025
Q1
$256K Sell
11,690
-4,989
-30% -$124K ﹤0.01% 1859
2024
Q4
$404K Buy
+16,679
New +$368K ﹤0.01% 1556
2024
Q2
Sell
-11,237
Closed -$400K 2159
2024
Q1
$400K Buy
+11,237
New +$336K ﹤0.01% 1379
2023
Q4
Sell
-14,988
Closed -$463K 2266
2023
Q3
$463K Buy
14,988
+9,370
+167% +$324K ﹤0.01% 1446
2023
Q2
$224K Sell
5,618
-2,277
-29% -$82.8K ﹤0.01% 1783
2023
Q1
$305K Buy
+7,895
New +$313K ﹤0.01% 1705

Other funds holding ALNT

HRT Financial's ALNT Position: Q1 2026 in Review

HRT Financial opened a new position in Allient (ALNT) in Q1 2026: 7,017 shares worth $414K. The stake represents ﹤0.01% of the portfolio and ranks #2664 among its holdings. This is a return to the name: HRT Financial previously reported a position in ALNT as recently as Q2 2025.

HRT Financial first reported a position in ALNT in Q1 2023 and has held it in 8 quarters since. The position peaked at $785K in Q2 2025. 213 funds tracked by Wall St. Rank hold ALNT as of Q1 2026.

  • HRT Financial held 7,017 shares of Allient worth $414K as of Q1 2026.
  • Allient was a new HRT Financial position in Q1 2026.
  • Allient made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2664 holding.
  • HRT Financial first reported a position in Allient in Q1 2023 and has held it in 8 quarters since.
  • HRT Financial's Allient position peaked at $785K in Q2 2025.
  • 213 funds tracked by Wall St. Rank held Allient as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.